EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Beyond Conventional Drug Design: Exploring the Broad‐Spectrum Efficacy of Antimicrobial Peptides

Tope T Odunitan iD, Boluwatife T Apanisile, Justinah A Afolabi, Praise O Adeniwura, Modinat W Akinboade, Najahtulahi O Ibrahim, Kehinde P Alare, Oluwatosin A Saibu, Oyindamola A Adeosun, Hammed S Opeyemi, Kolawole S Ayiti

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202401349 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Tope T Odunitan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomosho, Oyo State, Nigeria. Hauptthemen laut MEDLINE: Drug Design, Antimicrobial Peptides. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 219 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the fight against pathogenic infections, antimicrobial peptides (AMPs) constitute a novel and promising class of compounds that defies accepted drug development conventions like Lipinski's rule. AMPs are remarkably effective against a variety of pathogens, including viruses, bacteria, parasites, and fungi. Their effectiveness, despite differing from traditional drug‐like properties defies accepted standards. This review investigates the complex world of AMPs with an emphasis on their structural and physicochemical properties, which include size, sequence, structure, charge, and half‐life. These distinguishing characteristics set AMPs apart from conventional therapeutics that adhere to Lipinski's rules and greatly contribute to their selective targeting, reduction of resistance, multifunctionality, and broad‐spectrum efficacy. In contrast to traditional drugs that follow Lipinski's guidelines, AMPs have special qualities that play a big role in their ability to target specific targets, lower resistance, and work across a wide range of conditions. Our work is unique because of this nuanced investigation, which offers a new viewpoint on the potential of AMPs in tackling the worldwide problem of antibiotic resistance. In the face of the escalating global challenge of antibiotic resistance, antimicrobial peptides (AMPs) are innovative antimicrobial agents with unique mechanisms of action that challenge traditional Lipinski's Rule. They can withstand various microbial threats through membrane disruption, intracellular targeting, and immunomodulation. AMP versatility sets them apart from other antibiotics and their potential to address microbial infections and antibiotic resistance is growing. To fully unlock their potential, traditional drug development approaches need to be reconsidered. AMPs have revolutionary potential, paving the way for innovative solutions to health issues and transforming the antimicrobial therapy landscape.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DesignAntimicrobial PeptidesHumansMicrobial Sensitivity TestsAnti-Infective AgentsBacteriaFungiAnti-Bacterial Agents

Stichwörter der Autor:innen

AntimicrobialDrug designPathogensPeptideTherapy

Substanzen

Antimicrobial PeptidesAnti-Infective AgentsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomosho, Oyo State, Nigeria.
  • Genomics Unit, Helix Biogen Institute, Ogbomosho, Nigeria.
  • Department of Nutrition and Dietetics, Ladoke Akintola University of Technology, Ogbomosho, Oyo State, Nigeria.
  • Department of Medicine and Surgery, Ladoke Akintola University of Technology, Ogbomosho, Oyo State, Nigeria.
  • Department of Chemistry and Biochemistry, New Mexico State University, USA, Ibadan.
  • Department of Physiology, Ladoke Akintola University of Technology, Ogbomosho, Oyo State, Nigeria.

ORCID-Profile: Tope T Odunitan

Zitieren

APA

Odunitan, T. T., Apanisile, B. T., Afolabi, J. A., Adeniwura, P. O., Akinboade, M. W., Ibrahim, N. O., Alare, K. P., Saibu, O. A., Adeosun, O. A., Opeyemi, H. S., & Ayiti, K. S. (2025). Beyond Conventional Drug Design: Exploring the Broad‐Spectrum Efficacy of Antimicrobial Peptides. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401349

Vancouver

Odunitan TT, Apanisile BT, Afolabi JA, Adeniwura PO, Akinboade MW, Ibrahim NO, et al. Beyond Conventional Drug Design: Exploring the Broad‐Spectrum Efficacy of Antimicrobial Peptides. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202401349

BibTeX
@article{Odunitan2025,
  author = {Odunitan, Tope T and Apanisile, Boluwatife T and Afolabi, Justinah A and Adeniwura, Praise O and Akinboade, Modinat W and Ibrahim, Najahtulahi O and Alare, Kehinde P and Saibu, Oluwatosin A and Adeosun, Oyindamola A and Opeyemi, Hammed S and Ayiti, Kolawole S},
  title = {Beyond Conventional Drug Design: Exploring the Broad‐Spectrum Efficacy of Antimicrobial Peptides},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202401349}
}
Kostenlos starten →